Lacosamide Oral Solution
Product Images NDC 62135-885

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lacosamide Oral Solution (NDC 62135-885). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Chartwell Rx, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

"image Description" (Lacosamide Oral Solution 200ml Bottle Label)

Label for Lacosamide Oral Solution USP 10 mg/mL, a 200 mL oral liquid medication. The label includes dosage strength, storage instructions, a barcode, NDC number 62135-885-22, and states Chartwell RX, LLC as the manufacturer. It also advises dispensing a medication guide and keeping the product out of reach of children.*

FDA Label Image

"image Description" (Lacosamide Oral Solution Graph 1)

A bar chart showing seizure reduction percentages during a 'Mudan Tai Quarter Bottoming' test across three studies. Each study compares placebo vs. Lacosamide at different dosages (400 mg/day, 600 mg/day, 250 mg/day, 400 mg/day). Lacosamide consistently shows higher seizure reduction percentages compared to placebo, with values ranging from approximately 26% to 40% versus placebo values from 10% to 21%. Statistical significance compared to placebo is noted.*

FDA Label Image

"image Description" (Lacosamide Oral Solution Graph 2)

A cumulative distribution plot showing the responder rate in terms of percent change from baseline in seizure frequency over the number of patients for placebo and three different dosages of lacosamide (200 mg/day, 400 mg/day, 600 mg/day). The vertical axis represents the responder rate (equal to or greater percent change), ranging from worsening to improvement, and the horizontal axis represents the percent of patients.*

FDA Label Image

"image Description" (Lacosamide Oral Solution Graph 3)

A Kaplan-Meier survival curve graph showing proportion of patients on the y-axis versus time in days on the x-axis. The graph compares two groups: Placebo (N=121) and Lacosamide (N=118), depicting higher patient survival proportion over time for Lacosamide. The graph includes statistical values: p-value=0.001, hazard ratio=0.548, and 95% confidence interval [0.381, 0.788]. Number at risk counts for both groups are listed below the x-axis at various time points.*

FDA Label Image

"image Description" (Lacosamide Oral Solution Structure)

Chemical structure diagram of lacosamide, showing its molecular framework including an acetamide group, an amino acid backbone, an ether group, and a benzyl group. This illustrates the active ingredient of Lacosamide Oral Solution 10 mg/mL by Chartwell RX, LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.